All Type of News
More OTC small wholesalers forced into bankruptcy
A growing number of small-and mid-sized OTC (over-the-counter) drug wholesalers here will go out of business in the years to come, due largely to a fiercer competition among wholesalers amid the global economic downtu...
Korea’s drug sales index fall in July
Korea’s drug sales index posting 97.0 showed a slide of 1.3 percent in July from a year earlier, an institutional investor said Monday.
According to Shinhan Investment, the domestic drug shipment index rose 4.9 per...
Drug makers increase cashable assets amid economic woes and unpredictable variables
Influenced by persistent market uncertainty together with worsening business conditions, Korean pharmaceutical firms are choosing to hold more of their earnings in cashable assets as they find it harder to invest.
...
Celltrion’s Remsia in spotlight
Celltrion’s biosimilar monoclonal antibody Remsima (infliximab) is currently under the industry spotlight after the company gained market authorization from the European Commission on August 28.
The clinical report...
Pharmaceutical market polarization deepens
Despite their relatively large assets, the nation’s 54 Korean pharmaceutical companies spend considerably less on research and development (R&D) than promotional expenses, industry data showed recently.
According ...
Government’s plan to allow exclusive sales of pregnancy reagents by medical device vendors stirs deb
The Ministry of Food and Drug Safety (MFDS)’s plan, under which medical device vendors are allowed to exclusively market pregnancy tester other than pharmacies or drug wholesalers, is mired in controversy as questions...
Daewoong gets US prequalification approval for carbapenem antibiotic
A Korean antibiotic drug has won prequalification approval from the Food and Drug Administration of the United States for sale in the country, the company said Monday, a move that will give the local drugmaker access ...
Listed drugmakers see marketing expenses fall in H1
Korean drug manufacturers saw a contraction in their marketing outlays in the first half on a year-on-year basis, apparently hit by weaker bottom line due to the government-mandated cuts in drug prices last year.
A...
Debate ignites on integrated sales of pregnancy diagnostic reagents
The debate on whether to allow exclusive sales of pregnancy diagnostic reagents by medical device vendors is surfacing after the Ministry of Food and Drug Safety (MFDS) reviewed the issues last Friday.
All eyes are...
Wholesalers threaten to boycott Bayer products at pharmacy
Local drug wholesalers will join a nationwide campaign to boycott Bayer Korea products at drugstores to protest the company’s plan to slash the wholesalers’ profit margin from October.
Officials from the Korea Phar...
